As of April, 2021, we have a brand new non-stimulant medication approved for treatment of ADHD in the US. Are we excited? Does this represent an advance over other efforts to produce effective non-stimulant medications for ADHD, or is it another instance of ‘me too’? What does the supporting research tell us? And what side effects do we need to watch out for? Read and learn.

Naloxone, a rescue medication effective for reversing opioid overdose, will soon be available in two generic forms for layperson use. This news of note summarizes these generic, lower-cost products.